Updated EMBER-3 Trial Efficacy Results
I'm sharing updated efficacy results from the EMBER-3 trial, a phase 3 trial investigating an oral SERD with or without a CDK4/6i in patients with ER+,HER2- advanced breast cancer.
Click here to access the publication: e.lilly/3MvMyVB
#BreastCancer #SERD